Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.5K Buy
509
+140
+38% +$9.15K ﹤0.01% 642
2026
Q1
$16.9K Buy
369
+279
+310% +$16.1K ﹤0.01% 844
2025
Q4
$6.7K Buy
90
+48
+114% +$3.46K ﹤0.01% 850
2025
Q3
$3.07K Buy
42
+7
+20% +$533 ﹤0.01% 950
2025
Q2
$2.42K Hold
35
﹤0.01% 968
2025
Q1
$1.58K Hold
35
﹤0.01% 1036
2024
Q4
$2.13K Hold
35
﹤0.01% 982
2024
Q3
$1.43K Hold
35
﹤0.01% 1024
2024
Q2
$1.06K Hold
35
﹤0.01% 1066
2024
Q1
$1.3K Hold
35
﹤0.01% 975
2023
Q4
$1.72K Buy
+35
New +$1.01K ﹤0.01% 921
2023
Q3
Sell
-35
Closed -$537 241
2023
Q2
$537 Hold
35
﹤0.01% 974
2023
Q1
$394 Buy
+35
New +$441 ﹤0.01% 955

Other funds holding AFRM

CVA Family Office's AFRM Position: Q2 2026 in Review

CVA Family Office increased its Affirm (AFRM) stake by 38% in Q2 2026, buying an estimated $9.15K and bringing the position to 509 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

CVA Family Office first reported a position in AFRM in Q1 2023 and has held it in 13 quarters since. 656 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • CVA Family Office held 509 shares of Affirm worth $41.5K as of Q2 2026.
  • CVA Family Office bought 140 Affirm shares in Q2 2026, an estimated $9.15K.
  • Affirm made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #642 holding.
  • CVA Family Office first reported a position in Affirm in Q1 2023 and has held it in 13 quarters since.
  • 656 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.